Federal Reserve Economic Data

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Liabilities (QFRTCL385USNO)

Observation:

Q2 2024: 405,489 (+ more)   Updated: Sep 10, 2024 9:07 AM CDT
Q2 2024:  405,489  
Q1 2024:  376,175  
Q4 2023:  392,419  
Q3 2023:  349,564  
Q2 2023:  348,216  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Liabilities [QFRTCL385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFRTCL385USNO, .

RELATED DATA AND CONTENT


Subscribe to the FRED newsletter


Follow us

Back to Top
Top